Abilify and Aceon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify and Aceon. Common interactions include antipsychotic drug level increased among females and diabetes mellitus among males.

The phase IV clinical study analyzes what interactions people who take Abilify and Aceon have. It is created by eHealthMe based on reports of 7 people who take Abilify and Aceon from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 20, 2023

7 people who take Abilify and Aceon together, and have interactions are studied.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 98,584 Abilify users for its effectiveness, alternative drugs and more.

What is Aceon?

Aceon has active ingredients of perindopril erbumine. It is often used in high blood pressure. eHealthMe is studying from 1,785 Aceon users for its effectiveness, alternative drugs and more.

Number of Abilify and Aceon reports submitted per year:

Common Abilify and Aceon drug interactions by gender *:

female:

Antipsychotic drug level increased
Blood cholesterol increased
Blood glucose increased
Body temperature fluctuation
Diabetic ketoacidosis
Metabolic syndrome
Temperature regulation disorder
Type 2 diabetes mellitus
Vision blurred
Visual field defect

male:

Diabetes mellitus
Diabetes mellitus inadequate control
Metastases to liver
Pancreatic carcinoma metastatic
Tardive dyskinesia

Common Abilify and Aceon drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Metastases to liver
Pancreatic carcinoma metastatic
Tardive dyskinesia
Vision blurred
Diabetes mellitus
Diabetes mellitus inadequate control

60+:

Amnesia
Blood pressure fluctuation
Body temperature fluctuation
Diabetes insipidus
Metabolic syndrome
Neuroleptic malignant syndrome
Rhinorrhoea
Visual impairment

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Aceon?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Krishnan K, Krishnasamy K, "Evaluation of anaphylactic reaction as an adverse event for perindopril erbumine tablets", International Current Pharmaceutical Journal, 2014 Mar .